Back to dashboard
CommercialAdministrativeLow impact

11.02.25j, Transcatheter Cardiac Valve Procedures

Independence Blue Cross·PA · Cardiology, Cardiothoracic Surgery·Medical Policy
Effective date
Not stated
We identified it
Jun 19, 2026
Days to comply
—

Summary

Independence Blue Cross has reissued policy 11.02.25k for Transcatheter Cardiac Valve Procedures, superseding version 11.02.25j. The policy continues to cover TAVR for native valve aortic stenosis and degenerated bioprosthetic valves ('valve-in-valve') under specified clinical criteria. An ICD-10 code (Q23.88) was added in October 2024 for congenital malformations of aortic and mitral valves. No substantive coverage changes are documented; this is a routine policy reissuance communicating the company's continuing position.

Action Required

Action needed
No immediate action required. The policy 11.02.25k supersedes 11.02.25j and is available on the IBX policy portal. Billing team should verify that current billing system and templates reference policy version 11.02.25k (not 11.02.25j) for TAVR procedures. Confirm that ICD-10 code Q23.88 is active in the system for coding congenital aortic and mitral valve malformations effective October 1, 2024. Ensure providers continue to document NYHA classification, valve area measurements, and facility/provider credentialing per AHA/ACC/ACCF/SCAI/AATS/STS standards for all TAVR claims.

Affected Billing Codes

33361
33362
33363
33364
I06.0
I06.2
I34.0
I35.0
I35.2
Q22.4
Q22.8
Q22.9
Q23.0
Q23.1
Q23.2
Q23.3
Q23.88